Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|16|2|130-142

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.16, Iss.2, 2018-01, pp. : 130-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Obesity, Cardiovascular Risk and Pharmacotherapy

By  

Blood Pressure, Vol. 11, Iss. 5, 2002-11 ,pp. : 260-262

Informa Healthcare

Access to resources Recommend Favorite

Erectile Dysfunction and Cardiovascular Risk Factors

By  

World Heart Journal, Vol. , Iss. , 2017-01 ,pp. : 61-60

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Cardiovascular Risk in Hypertensive Patients with Renal Dysfunction

By Ravera Maura   Re Michela   Weiss Ursula   Cannavo' Rossella   Deferrari Luca   Deferrari Giacomo  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

Intracavernous Pharmacotherapy for Erectile Dysfunction

By Bella Anthony J.   Brock Gerald B.  

Endocrine Journal, Vol. 23, Iss. 2-3, 2004-03 ,pp. : 149-156

Humana Press, Inc

Access to resources Recommend Favorite

Assessment of Cardiovascular Risk in Patients with Erectile Dysfunction: Focus on the Diabetic Patient

By Kloner Robert A.  

Endocrine Journal, Vol. 23, Iss. 2-3, 2004-03 ,pp. : 125-130

Humana Press, Inc

Access to resources Recommend Favorite